Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-01T12:41:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.2%
    Check dated 2026-10-25T12:56:30.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer's site revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T13:09:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T14:41:17.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.7.0 as the latest update, and the previous Revision: v3.6.6 is removed from the list.
    Difference
    0.0%
    Check dated 2026-09-20T19:42:00.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the Study Record History, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-30T20:53:12.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.